ABT vs BRKR
Abbott Laboratories · Bruker Corporation
Relative return (rebased to 100)
Key stats
| Metric | ABT | BRKR |
|---|---|---|
| Price | $101.29 | $64.18 |
| Market Cap | $176.43B | $9.78B |
| P/E | 27.04 | — |
| P/B | 3.39 | 4.07 |
| P/S | 3.98 | 2.85 |
| ROE | 12.5% | -0.4% |
| Net Margin | 14.7% | -0.3% |
| Gross Margin | — | 45.9% |
| Revenue Growth | 5.7% | 2.1% |
| Dividend Yield | 2.37% | 0.31% |
| EPS | $3.75 | -$0.06 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.